clinic
implic
csection
cesarean
section
iqr
interquartil
rang
data
express
n
unless
otherwis
indic
atop
condit
includ
asthma
allerg
rhiniti
food
allergi
eczema
acidsuppress
medic
commonli
use
pregnanc
cohort
us
children
high
risk
asthma
due
sever
bronchiol
infanc
found
prenat
exposur
acidsuppress
medic
increas
risk
develop
recurr
wheez
futur
research
need
topic
interim
clinician
may
wish
discuss
patient
potenti
risk
benefit
acidsuppress
medic
use
pregnanc
asthma
one
common
chronic
diseas
childhood
develop
complex
interact
genet
suscept
environment
exposur
unit
state
acidsuppress
medic
asm
avail
wide
either
prescript
overthecount
purchas
commonli
use
throughout
lifespan
includ
pregnanc
recent
evid
outsid
unit
state
suggest
prenat
exposur
asm
may
associ
increas
risk
asthma
children
previou
studi
perform
mostli
european
popul
conduct
retrospect
larg
databas
thu
reli
primarili
prescript
record
diagnosi
code
identifi
exposur
outcom
despit
effort
control
bia
confound
retrospect
observ
studi
potenti
affect
misclassif
exposur
outcom
inabl
adjust
variou
factor
includ
matern
atopi
object
evalu
whether
prenat
exposur
asm
increas
risk
recurr
wheez
popul
raciallyethn
divers
us
children
alreadi
high
risk
develop
asthma
due
sever
bronchiol
infanc
investig
multicent
airway
research
collabor
cohort
compos
children
histori
sever
bronchiol
infanc
popul
novel
due
racialethn
divers
well
increas
risk
develop
asthma
due
bronchiol
event
among
particip
longitudin
cohort
complet
exposur
outcom
data
exposur
defin
parent
report
matern
use
asm
pregnanc
either
receptor
antagonist
proton
pump
inhibitor
outcom
recurr
wheez
age
year
defin
per
nation
institut
health
asthma
guidelin
least
corticosteroidrequir
exacerb
within
month
least
wheez
episod
within
year
last
least
day
affect
sleep
unadjust
adjust
analys
perform
use
coxproport
hazard
model
stratifi
age
multivari
model
adjust
potenti
confound
use
stata
se
colleg
station
texa
detail
method
result
see
articl
onlin
repositori
wwwjaciinpracticeorg
cohort
geograph
racialethn
divers
children
unit
state
mother
report
use
asm
pregnanc
tabl
mother
report
use
month
less
month
month
month
less
unknown
durat
use
enrol
median
total
serum
ige
level
differ
significantli
expos
children
kul
interquartil
rang
compar
unexpos
children
kul
interquartil
rang
p
recurr
wheez
develop
children
age
year
unexpos
children
develop
recurr
wheez
compar
expos
children
unadjust
hazard
ratio
hr
ci
increas
risk
persist
despit
adjust
potenti
confound
adjust
hr
ci
tabl
ii
see
figur
articl
onlin
repositori
wwwjaciinpracticeorg
although
statist
power
low
perform
exploratori
analys
investig
relationship
durat
exposur
asm
pregnanc
risk
recurr
wheez
expos
less
month
pregnanc
lower
risk
develop
recurr
wheez
adjust
hr
ci
expos
month
pregnanc
adjust
hr
ci
knowledg
first
studi
investig
prenat
exposur
asm
recurr
wheez
prospect
us
basedcohort
first
investig
issu
among
infant
high
risk
develop
asthma
studi
design
analysi
enabl
us
limit
sever
potenti
sourc
bia
direct
ascertain
matern
asm
use
parent
decreas
misclassif
exposur
unit
state
matern
report
asm
use
like
superior
medic
record
document
due
avail
medic
overthecount
purchas
report
mother
use
asm
pregnanc
howev
baselin
popul
rate
asm
use
pregnanc
unit
state
accur
identifi
easi
overthecount
purchas
recurr
wheez
determin
detail
parent
interview
everi
month
consist
current
nation
institut
health
guidelin
thu
expect
less
outcom
misclassif
cohort
raciallyethn
divers
nonwhit
may
generaliz
us
popul
previou
studi
perform
primarili
european
popul
final
gather
detail
inform
directli
children
parent
regard
mani
potenti
confound
includ
parent
histori
allerg
diseas
sociodemograph
perinat
factor
despit
adjust
prenat
asm
exposur
consist
associ
develop
recurr
wheez
main
analys
underli
mechan
asm
may
increas
risk
recurr
wheez
subsequ
asthma
known
evid
suggest
asm
includ
proton
pump
inhibitor
receptor
antagonist
may
predispos
allerg
sensit
propens
express
h
cytokin
dysbiosi
microbiom
effect
thought
relat
common
function
suppress
gastric
acid
studi
found
signific
differ
total
ige
expos
unexpos
infant
howev
sampl
collect
enrol
median
age
month
may
either
distant
exposur
earli
infanc
detect
meaning
differ
likewis
role
microbiom
increasingli
recogn
develop
asthma
howev
research
need
determin
whether
asm
use
associ
alter
microbiom
predispos
individu
develop
asthma
limit
studi
includ
observ
design
preclud
strong
statement
causal
despit
effort
adjust
confound
possibl
unmeasur
confound
remain
includ
confound
indic
prenat
exposur
asm
obtain
time
studi
enrol
rais
possibl
recal
bia
howev
children
young
infant
median
age
month
time
enrol
current
hospit
acut
ill
thu
would
expect
matern
recal
bia
basi
natur
data
limit
abil
determin
trimest
exposur
effect
asm
may
greatest
mother
report
use
asm
least
month
inher
account
exposur
trimest
children
cohort
high
risk
develop
recurr
wheez
due
share
histori
sever
bronchiol
infanc
limit
generaliz
studi
howev
bronchiol
rare
infect
childhood
common
caus
hospit
us
infant
hospitalizationsi
thu
although
studi
generaliz
children
generaliz
larg
patient
popul
conclus
prenat
asm
exposur
appear
increas
risk
recurr
wheez
children
histori
sever
bronchiol
infanc
find
import
prenat
exposur
asm
modifi
although
research
need
lowrisk
popul
clinician
may
wish
discuss
potenti
risk
benefit
elect
asm
therapi
initi
pregnanc
continu
follow
children
develop
asthma
plan
investig
associ
asm
exposur
import
outcom
encourag
futur
research
risk
asm
exposur
lowrisk
gener
popul
risk
bronchiol
prenat
exposur
asm
potenti
dosedepend
trimesterdepend
effect
asm
exposur
potenti
confound
includ
confound
indic
elucid
potenti
underli
mechan
model
adjust
sex
insur
raceethn
median
household
incom
model
b
adjust
sex
insur
raceethn
median
household
incom
matern
histori
atop
diseas
asthma
allerg
rhiniti
food
allergi
eczema
matern
smoke
pregnanc
gestat
age
birth
multipl
gestat
eg
twin
mode
deliveri
matern
use
antibiot
pregnanc
labor
model
stratifi
age
enrol
signific
p
multicent
airway
research
collabor
multicent
prospect
cohort
studi
infant
younger
year
enrol
episod
sever
bronchiol
sever
bronchiol
defin
need
hospit
studi
conduct
site
unit
state
use
standard
protocol
detail
previous
publish
children
met
end
point
recurr
wheez
studi
entri
exclud
enrol
children
studi
children
follow
longitudin
cohort
analyt
cohort
present
analysi
defin
particip
longitudin
cohort
complet
exposur
outcom
data
time
enrol
parent
particip
detail
inperson
interview
captur
demograph
parent
health
perinat
child
health
inform
subject
parent
subsequ
underw
structur
telephon
interview
train
studi
staff
everi
month
blood
sampl
obtain
particip
enrol
serum
analyz
multipl
paramet
includ
total
ige
level
allergen
test
perform
phadia
immunolog
refer
laboratori
portag
mich
analysi
predetermin
secondari
analysi
studi
approv
institut
review
board
particip
site
conduct
accord
good
clinic
practic
standard
written
inform
consent
obtain
parent
guardian
studi
subject
inform
matern
use
asm
proton
pump
inhibitor
receptor
antagonist
pregnanc
obtain
parent
questionnair
enrol
follow
question
use
determin
exposur
statu
pregnant
child
youth
biolog
mother
take
blocker
proton
pump
inhibitor
gastroesophag
reflux
heartburn
gerd
ulcer
exampl
provid
respond
instruct
includ
antacid
respons
ye
ask
mani
month
pregnanc
yoush
take
medic
outcom
recurr
wheez
age
year
defin
per
nation
institut
health
asthma
guidelin
least
corticosteroidrequir
exacerb
within
month
least
wheez
episod
within
year
last
least
day
affect
sleep
outcom
continu
assess
structur
telephon
interview
parent
everi
month
first
month
life
breath
problem
detail
inform
gather
includ
date
onset
symptom
durat
symptom
effect
sleep
medic
care
receiv
medic
use
enrol
parent
provid
detail
inform
regard
multipl
covari
includ
demograph
characterist
raceethn
nonhispan
white
nhw
nonhispan
black
nhb
hispan
insur
statu
matern
patern
histori
allerg
condit
asthma
allerg
rhiniti
food
allergi
eczema
matern
smoke
pregnanc
gestat
age
birth
child
birth
weight
multipl
gestat
eg
twin
mode
deliveri
matern
use
antibiot
pregnanc
child
health
studi
enrol
household
incom
enrol
estim
basi
median
household
incom
zip
code
obtain
esri
arcgi
busi
analyst
desktop
redland
calif
summari
data
demograph
characterist
matern
factor
compar
use
pearson
chisquar
test
categor
variabl
mannwhitney
u
test
continu
variabl
appropri
unadjust
adjust
hr
calcul
use
coxproport
hazard
model
stratifi
age
child
enrol
assumpt
proport
hazard
verifi
use
schoenfeld
residu
hazard
age
enrol
proport
time
thu
multivari
model
specifi
stratifi
age
two
adjust
model
use
assess
effect
potenti
confound
first
model
adjust
sociodemograph
factor
includ
sex
raceethn
median
household
incom
fulli
adjust
model
adjust
sex
raceethn
median
household
incom
matern
histori
atopi
asthma
allerg
rhiniti
food
allergi
eczema
matern
smoke
pregnanc
gestat
age
birth
multipl
gestat
eg
twin
mode
deliveri
matern
use
antibiot
pregnanc
labor
covari
includ
model
determin
priori
basi
current
understand
biolog
model
perform
stratifi
analysi
race
ethnic
nhw
nhb
hispan
includ
full
adjust
potenti
confound
list
addit
perform
analysi
basi
durat
exposur
asm
pregnanc
asm
use
month
use
month
use
includ
full
adjust
potenti
confound
statist
signific
determin
p
valu
less
expos
cohort
primarili
compos
nhw
children
insur
privat
median
household
incom
greater
equal
tabl
signific
differ
asmexpos
asmunexpos
group
type
viral
pathogen
isol
initi
bronchiol
event
signific
differ
sever
initi
bronchiol
event
intens
care
unit
admiss
intub
tabl
although
statist
power
low
perform
exploratori
analysi
differ
racialethn
group
found
adjust
hr
major
group
nhw
ci
nhb
ci
hispan
ci
excess
risk
among
hispan
prenat
exposur
asm
statist
signific
p
interact
